Gedatolisib
Gedatolisib is a drug that targets phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway and has potential anti-tumor activity.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0148 |
| Pricing | 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, inquire |